Arthroscopic second generation autologous chondrocyte implantation

Area of Science:

• Orthopedic Surgery
• Regenerative Medicine
• Biomaterials Science

Background:

• Cartilage defects are a common cause of knee pain and disability.
• Autologous chondrocyte transplantation (ACT) is a viable treatment option for articular cartilage repair.
• Hyaluronan-based scaffolds offer biocompatible and biodegradable matrices for cell delivery.

Purpose of the Study:

• To evaluate the clinical outcomes of arthroscopic matrix-assisted autologous chondrocyte transplantation (MACT).
• To establish clear indication criteria for MACT in treating chondral lesions.
• To assess the efficacy of a hyaluronan-based scaffold in cartilage regeneration.

Main Methods:

• Prospective study of 70 consecutive patients undergoing arthroscopic MACT.
• Minimum follow-up of 24 months (47 patients with 36+ months, 21 patients with 48+ months).
• Analysis of clinical outcomes, including isolated and associated chondral lesions (e.g., ACL, meniscal).

Main Results:

• Statistically significant clinical improvement observed at 24 months post-procedure.
• Second-look arthroscopy showed complete coverage with hyaline cartilage-like tissue in 12/15 patients.
• Better outcomes noted in younger, well-trained patients and traumatic lesions; defect size, location, and prior surgery showed no significant impact.

Conclusions:

• Arthroscopic MACT with a hyaluronan-based scaffold is effective for cartilage repair.
• The procedure simplifies treatment, reduces morbidity, and shortens recovery time.
• Patient selection (young, active, traumatic lesions) is key for optimal results.